osimertinib
Genprex,Astrazeneca
['nsclc', 'sclc']
icymi: will seek to enroll approximately 66 patients in the phase 2 expansion portion. #asco23 #nsclc #$gnpx read more: 
CGTLive™ delivers quality and relevant information to healthcare professionals on cell, gene, regenerative, and engineered medicines to ultimately improve care.